Truncating variants in PAPSS2 gene: A cause of early prenatal onset brachyolmia?

Giulia Biancotto,Giulia Rosti,Francesca Madia,Valeria Capra,Marcello Scala,Elena Aleo,Dario Paladini
DOI: https://doi.org/10.1002/pd.6596
2024-05-22
Prenatal Diagnosis
Abstract:Brachyolmia is a rare form of skeletal dysplasia characterized by a wide genetic and clinical heterogeneity. This condition is usually diagnosed postnatally, and very few cases of prenatal diagnosis have been described so far. Here, we report a case of a pregnant woman at 20 weeks' gestation referred to our center because of fetal short long bones. On targeted ultrasound, mild bowing of the femurs and fibulae and mild micrognathia were also observed. Exome sequencing analysis showed the presence in compound heterozygosity of two pathogenic variants—both truncating variants—in the 3‐prime‐phosphoadenosine 5‐prime‐phosphosulfate synthase 2 (PAPSS2) gene, known to cause brachyolmia type 4 (OMIM #612847). Of note, all of the few cases reported prenatally have indeed truncating variants. Hence, we speculate this kind of variant is likely responsible for a complete loss of function of the protein leading to an earlier and more severe phenotype.
genetics & heredity,obstetrics & gynecology
What problem does this paper attempt to address?